Showing results 1 to 6 of 6
Title | Author(s) | Issue Date | |
---|---|---|---|
2018 | |||
Biomarker Signatures Correlate with Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus Journal:Molecular Cancer Therapeutics | 2015 | ||
Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing Journal:Clinical Cancer Research | 2015 | ||
A leave-one-out cross-validation SAS macro for the identification of markers associated with survival Journal:Computers in Biology and Medicine | 2015 | ||
Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105 Journal:Molecular Cancer Therapeutics | 2018 | ||
2014 |